Beijing Tong Ren Tang Chinese Medicine Company Limited (SEHK: 3613)
Health Care · Pharmaceuticals · HK
HK$5.57
+0.18% today · -37.8% 1Y
Beijing Tong Ren Tang Chinese Medicine Company Limited (SEHK: 3613) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $594.15M and employs 763 people.
Over the last twelve months the share price has lost 37.8%, trading between 5.40 and 9.50.
Tweenvest scores Beijing Tong Ren Tang Chinese Medicine Company Limited across four factors: quality 87/100, value 87/100, growth 18/100, dividend 87/100. Its strongest factor is quality.
3613 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $594.15M
- Revenue (TTM)
- $172.60M
- P/E
- 12.93
- EPS
- 0.43
- Dividend yield
- 6.65%
- Beta (5Y)
- 0.35
- 52-week high
- HK$9.50
- 52-week low
- HK$5.40
- Avg volume (3M)
- —
- Shares outstanding
- 837.10M
- Employees
- 763
- Next earnings
- —
About Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.
- ISIN
- HK0000145638
- Founded
- 1669
- Listed since
- May 7, 2013
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hainan Shuangcheng Pharmaceuticals Co., Ltd.SZSE: 002693 | $606.73M | CN¥9.80 | +6.29% |
| Nanjing Hicin Pharmaceutical Co., Ltd.SZSE: 300584 | $600.53M | CN¥33.52 | +7.50% |
| Aquestive Therapeutics, Inc.NasdaqGM: AQST | $599.95M | $4.78 | +5.05% |
| Jinhe Biotechnology CO., LTD.SZSE: 002688 | $597.95M | CN¥5.30 | +1.92% |
| ChengDu ShengNuo Biotec Co.,Ltd.SHSE: 688117 | $593.11M | CN¥18.03 | -2.86% |
| Tibet Weixinkang Medicine Co., Ltd.SHSE: 603676 | $592.53M | CN¥9.18 | +0.99% |
| Middle East Pharmaceutical Industries CompanySASE: 4016 | $589.61M | SR63.25 | +1.69% |
| Hefei Lifeon Pharmaceutical Co., Ltd.SZSE: 003020 | $589.45M | CN¥17.30 | +0.23% |
Figures last refreshed Oct 11, 2026.